Levine Fallout Begins: Supreme Court Remands Two Drug Product Liability Cases to Trial Courts

On Monday the high court vacated a pair of Third Circuit preemption rulings, sending cases against GlaxoSmithKline and AstraZeneca back down to lower courts in the wake of last week's landmark Levine ruling. Expect lots more of the same in the weeks and months to come, as the de facto freeze on personal injury pharmaceutical suits lifts. Plus: a modest proposal for handling drug cases from the Manhattan Institute.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to LexisAdvance®.

Continue to LexisAdvance®

Not a LexisAdvance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via LexisAdvance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com